rG4detector, a novel RNA G-quadruplex predictor, uncovers their impact on stress granule formation

Maor Turner, Yehuda M. Danino, Mira Barshai, Nancy S. Yacovzada, Yahel Cohen, Tsviya Olender, Ron Rotkopf, David Monchaud, Eran Hornstein, Yaron Orenstein

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

RNA G-quadruplexes (rG4s) are RNA secondary structures, which are formed by guanine-rich sequences and have important cellular functions. Existing computational tools for rG4 prediction rely on specific sequence features and/or were trained on small datasets, without considering rG4 stability information, and are therefore sub-optimal. Here, we developed rG4detector, a convolutional neural network to identify potential rG4s in transcriptomics data. rG4detector outperforms existing methods in both predicting rG4 stability and in detecting rG4-forming sequences. To demonstrate the biological-relevance of rG4detector, we employed it to study RNAs that are bound by the RNA-binding protein G3BP1. G3BP1 is central to the induction of stress granules (SGs), which are cytoplasmic biomolecular condensates that form in response to a variety of cellular stresses. Unexpectedly, rG4detector revealed a dynamic enrichment of rG4s bound by G3BP1 in response to cellular stress. In addition, we experimentally characterized G3BP1 cross-talk with rG4s, demonstrating that G3BP1 is a bona fide rG4-binding protein and that endogenous rG4s are enriched within SGs. Furthermore, we found that reduced rG4 availability impairs SG formation. Hence, we conclude that rG4s play a direct role in SG biology via their interactions with RNA-binding proteins and that rG4detector is a novel useful tool for rG4 transcriptomics data analyses.

Original languageEnglish
Pages (from-to)11426-11441
Number of pages16
JournalNucleic Acids Research
Volume50
Issue number20
DOIs
StatePublished - 11 Nov 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Funding

Research in the Orenstein lab was supported by the Israel Cancer Association [20221519]; Israel Science Foundation [358/21]; Israeli Council for Higher Education (CHE) via Data Science Research Center, Ben-Gurion University of the Negev, Israel; E.H. is the Mondry Family Professorial Chair at Weizmann Institute of Science; Research in the Hornstein lab is supported by Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation; CReATe consortium and ALSA (program: 'Prognostic Value of miRNAs in Biofluids From ALS Patients'); RADALA Foundation; AFM Telethon (20576); Weizmann-Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science; Minerva Foundation, with funding from the Federal German Ministry for Education and Research; ISF Legacy Heritage Fund [828/17]; Israel Science Foundation [135/16, 3497/21, 424/22, 425/22]; Target ALS [118945]; Thierry Latran Foundation for ALS Research; European Research Council under the European Union's Seventh Framework Program [[FP7/2007-2013]/ERC grant agreement number 617351]; United States-Israel Binational Science Foundation [2021181]; ERA-Net for Research Programs on Rare Diseases [eRARE FP7] via the Israel Ministry of Health; Dr Sydney Brenner and friends; Edward and Janie Moravitz; A. Alfred Taubman through IsrALS; Yeda-Sela; Yeda-CEO; Israel Ministry of Trade and Industry; Y. Leon Benoziyo Institute for Molecular Medicine; the Nella and Leon Benoziyo Center for Neurological Diseases; Kekst Family Institute for Medical Genetics; David and Fela Shapell Family Center for Genetic Disorders Research; Crown Human Genome Center; Nathan, Shirley, Philip and Charlene Vener New Scientist Fund; Julius and Ray Charlestein Foundation; Fraida Foundation; the Wolf-son Family Charitable Trust; Adelis Foundation; Merck (UK); M. Halphen; estates of F. Sherr, L. Asseof and L. Fulop; Goldhirsh-Yellin Foundation; Redhill Foundation-Sam and Jean Rothberg Charitable Trust; Dr Dvora and Haim Teitelbaum Endowment Fund; Anita James Rosen Foundation; Y.M.D. is funded by a fellowship from CNRS-WIS center for research of RNA secondary structures. Funding for open access charge: Same as funding grants. Conflict of interest statement. None declared. Research in the Orenstein lab was supported by the Israel Cancer Association [20221519]; Israel Science Foundation [358/21]; Israeli Council for Higher Education (CHE) via Data Science Research Center, Ben-Gurion University of the Negev, Israel; E.H. is the Mondry Family Professorial Chair at Weizmann Institute of Science; Research in the Hornstein lab is supported by Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation; CReATe consortium and ALSA (program: ‘Prognostic Value of miR-NAs in Biofluids From ALS Patients’); RADALA Foundation; AFM Telethon (20576); Weizmann–Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science; Minerva Foundation, with funding from the Federal German Ministry for Education and Research; ISF Legacy Heritage Fund [828/17]; Israel Science Foundation [135/16, 3497/21, 424/22, 425/22]; Target ALS [118945]; Thierry Latran Foundation for ALS Research; European Research Council under the European Union’s Seventh Framework Program [[FP7/2007–2013]/ERC grant agreement number 617351]; United States–Israel Binational Science Foundation [2021181]; ERA-Net for Research Programs on Rare Diseases [eRARE FP7] via the Israel Ministry of Health; Dr Sydney Brenner and friends; Edward and Janie Moravitz; A. Alfred Taubman through IsrALS; Yeda-Sela; Yeda-CEO; Israel Ministry of Trade and Industry; Y. Leon Benoziyo Institute for Molecular Medicine; the Nella and Leon Benoziyo Center for Neurological Diseases; Kekst Family Institute for Medical Genetics; David and Fela Shapell Family Center for Genetic Disorders Research; Crown Human Genome Center; Nathan, Shirley, Philip and Charlene Vener New Scientist Fund; Julius and Ray Charlestein Foundation; Fraida Foundation; the Wolf-son Family Charitable Trust; Adelis Foundation; Merck (UK); M. Halphen; estates of F. Sherr, L. Asseof and L. Fulop; Goldhirsh-Yellin Foundation; Redhill Foundation– Sam and Jean Rothberg Charitable Trust; Dr Dvora and Haim Teitelbaum Endowment Fund; Anita James Rosen Foundation; Y.M.D. is funded by a fellowship from CNRS-WIS center for research of RNA secondary structures. Funding for open access charge: Same as funding grants. Conflict of interest statement. None declared.

FundersFunder number
Anita James Rosen Foundation
CNRS-WIS
Federal German Ministry for Education and Research
Fraida Foundation
Goldhirsh-Yellin Foundation
Julius and Ray Charlestein Foundation
Redhill Foundation
Redhill Foundation-Sam and Jean Rothberg Charitable Trust
Sam and Jean Rothberg Charitable Trust
Weizmann-Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science
Wolf-son Family Charitable Trust
Merck
A. Alfred Taubman Medical Research Institute
Fondation Thierry Latran
Seventh Framework Programme
European Commission617351
Minerva Foundation
United States-Israel Binational Science Foundation2021181
Israel Cancer Association20221519
Israel Science Foundation358/21, 135/16, 118945, 3497/21, 424/22, 425/22, 828/17
Ministry of Industry, Trade and Labor
AFM-Téléthon20576
Seventh Framework Programme
Council for Higher Education
Ministry of Health, State of Israel
Crown Human Genome Center

    Fingerprint

    Dive into the research topics of 'rG4detector, a novel RNA G-quadruplex predictor, uncovers their impact on stress granule formation'. Together they form a unique fingerprint.

    Cite this